Compare · SNX vs WGS
SNX vs WGS
Side-by-side comparison of TD SYNNEX Corporation (SNX) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SNX and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- SNX is the larger of the two at $20.10B, about 7.7x WGS ($2.61B).
- Over the past year, SNX is up 70.1% and WGS is down 30.7% - SNX leads by 100.8 points.
- WGS has been more active in the news (8 items in the past 4 weeks vs 7 for SNX).
- SNX has more recent analyst coverage (22 ratings vs 8 for WGS).
- Company
- TD SYNNEX Corporation
- GeneDx Holdings Corp.
- Price
- $251.48+3.00%
- $87.40+2.58%
- Market cap
- $20.10B
- $2.61B
- 1M return
- +2.68%
- +44.27%
- 1Y return
- +70.08%
- -30.70%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2003
- 2020
- News (4w)
- 7
- 8
- Recent ratings
- 22
- 8
TD SYNNEX Corporation
SYNNEX Corporation provides business process services in the United States and internationally. The company distributes peripherals; and information technology systems, including system components, software, networking, communications and security equipment, consumer electronics, and complementary products, as well as designs and integrates data center equipment. It also provides systems design and integration solutions, build-to-order, and configure-to-order assembly capabilities; logistics services that comprise outsourced fulfillment, virtual distribution, and direct ship to end-users; cloud services; online services; and financing services comprising net terms, third party leasing, floor plan financing, and letters of credit backed financing and arrangements. In addition, the company offers marketing services, such as direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves resellers, system integrators, and retailers. The company was formerly known as SYNNEX Information Technologies, Inc. and changed its name to SYNNEX Corporation in October 2003. SYNNEX Corporation was founded in 1980 and is headquartered in Fremont, California.
Latest SNX
- Hyve Solutions Expands Manufacturing Footprint With Reno and North Las Vegas Campuses
- Chair, Hyve Solutions Polk Dennis sold $653,015 worth of shares (2,500 units at $261.21) as part of a pre-agreed trading plan (SEC Form 4)
- TD SYNNEX Expands IBM Distribution to Accelerate Partner-Led Growth Worldwide
- Director Hume Richard T sold $1,311,051 worth of shares (5,000 units at $262.21) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 13,537 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by TD SYNNEX Corporation
- TD SYNNEX Earns 2026 Great Place to Work Certification™
- TD SYNNEX Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Director Vezina Ann F sold $325,952 worth of shares (1,273 units at $256.05), decreasing direct ownership by 18% to 5,828 units (SEC Form 4)
- SEC Form 144 filed by TD SYNNEX Corporation
- TD SYNNEX Included in Forbes’ America’s Dream Employers 2026
Latest WGS
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Amendment: SEC Form SCHEDULE 13G/A filed by GeneDx Holdings Corp.
- GeneDx to Participate in Upcoming Investor Conferences
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports Second Quarter 2026 Financial Results
- SEC Form 25-NSE filed by GeneDx Holdings Corp.
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026